A Study of A166 in Patients With Advanced Solid Malignant Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: A166
Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.